BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34228109)

  • 1. Search for AL amyloidosis risk factors using Mendelian randomization.
    Saunders CN; Chattopadhyay S; Huhn S; Weinhold N; Hoffmann P; Nöthen MM; Jöckel KH; Schmidt B; Landi S; Goldschmidt H; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Schönland SO; Försti A; Houlston R; Hemminki K
    Blood Adv; 2021 Jul; 5(13):2725-2731. PubMed ID: 34228109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for multiple myeloma risk factors using Mendelian randomization.
    Went M; Cornish AJ; Law PJ; Kinnersley B; van Duin M; Weinhold N; Försti A; Hansson M; Sonneveld P; Goldschmidt H; Morgan GJ; Hemminki K; Nilsson B; Kaiser M; Houlston RS
    Blood Adv; 2020 May; 4(10):2172-2179. PubMed ID: 32433745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.
    da Silva Filho MI; Försti A; Weinhold N; Meziane I; Campo C; Huhn S; Nickel J; Hoffmann P; Nöthen MM; Jöckel KH; Landi S; Mitchell JS; Johnson D; Morgan GJ; Houlston R; Goldschmidt H; Jauch A; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Schönland SO; Hemminki K
    Leukemia; 2017 Aug; 31(8):1735-1742. PubMed ID: 28025584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The causal effect of interleukin-17 on the risk of psoriatic arthritis: a Mendelian randomization study.
    Wu D; Wong P; Lam SHM; Li EK; Qin L; Tam LS; Gu J
    Rheumatology (Oxford); 2021 Apr; 60(4):1963-1973. PubMed ID: 33188428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers in Immunoglobulin Light Chain Amyloidosis.
    Kufová Z; Sevcikova T; Growkova K; Vojta P; Filipová J; Adam Z; Pour L; Penka M; Rysava R; Němec P; Brozova L; Vychytilova P; Jurczyszyn A; Grosicki S; Barchnicka A; Hajdúch M; Simicek M; Hájek R
    Klin Onkol; 2017; 30(Supplementum2):60-67. PubMed ID: 28903572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance.
    Chattopadhyay S; Thomsen H; Weinhold N; Meziane I; Huhn S; da Silva Filho MI; Vodicka P; Vodickova L; Hoffmann P; Nöthen MM; Jöckel KH; Schmidt B; Landi S; Hajek R; Hallmans G; Pettersson-Kymmer U; Ohlsson C; Milani P; Merlini G; Rowcieno D; Hawkins P; Hegenbart U; Palladini G; Wechalekar A; Schönland SO; Houlston R; Goldschmidt H; Hemminki K; Försti A
    Leukemia; 2020 Apr; 34(4):1187-1191. PubMed ID: 31695157
    [No Abstract]   [Full Text] [Related]  

  • 7. AL amyloidosis with non-amyloid forming monoclonal immunoglobulin deposition; a case mimicking AHL amyloidosis.
    Manabe S; Iwasaki C; Hatano M; Kametani F; Yazaki M; Nitta K; Nagata M
    BMC Nephrol; 2018 Nov; 19(1):337. PubMed ID: 30466387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AL amyloidosis with a localized B cell neoplasia.
    Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
    Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the relationship between alcohol consumption, tobacco use, and cardiovascular disease: A multivariable Mendelian randomization study.
    Rosoff DB; Davey Smith G; Mehta N; Clarke TK; Lohoff FW
    PLoS Med; 2020 Dec; 17(12):e1003410. PubMed ID: 33275596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A unique case of light chain (AL) amyloidosis masquerading as hypophosphatemic osteomalacia.
    Malhotra R; Guleria P; Barwad A; Pramanik R; Tandon N
    Osteoporos Int; 2021 Feb; 32(2):387-392. PubMed ID: 32910218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of growth differentiation factor 15 on the risk of cardiovascular diseases: two-sample Mendelian randomization study.
    Wang Z; Yang F; Ma M; Bao Q; Shen J; Ye F; Xie X
    BMC Cardiovasc Disord; 2020 Oct; 20(1):462. PubMed ID: 33115406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of genetically determined iron status across the phenome: A mendelian randomization study.
    Gill D; Benyamin B; Moore LSP; Monori G; Zhou A; Koskeridis F; Evangelou E; Laffan M; Walker AP; Tsilidis KK; Dehghan A; Elliott P; Hyppönen E; Tzoulaki I
    PLoS Med; 2019 Jun; 16(6):e1002833. PubMed ID: 31220083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibril-directed Therapies in Systemic Light Chain AL Amyloidosis.
    Bhutani D; Leng S; Lentzsch S
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):555-559. PubMed ID: 31262668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Drug Targets for Ischemic Stroke Identified Through Mendelian Randomization Analysis of the Blood Proteome.
    Chong M; Sjaarda J; Pigeyre M; Mohammadi-Shemirani P; Lali R; Shoamanesh A; Gerstein HC; Paré G
    Circulation; 2019 Sep; 140(10):819-830. PubMed ID: 31208196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of renal function in a patient diagnosed with concurrent amyloid amyloidosis and immunoglobulin light chain amyloidosis.
    Watanabe R; Ito K; Yasuno T; Abe Y; Hamauchi A; Yasunaga T; Sasatomi Y; Hisano S; Saito T; Nakashima H
    Nihon Jinzo Gakkai Shi; 2016; 58(5):668-74. PubMed ID: 30375826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro co-expression of human amyloidogenic immunoglobulin light and heavy chain proteins: a relevant cell-based model of AL amyloidosis.
    Klimtchuk ES; Prokaeva TB; Spencer BH; Gursky O; Connors LH
    Amyloid; 2017 Jun; 24(2):115-122. PubMed ID: 28632419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local and systemic light chain amyloidosis in patients with rheumatic diseases].
    Veelken K; Hegenbart U; Schönland SO; Blank N
    Z Rheumatol; 2020 Sep; 79(7):660-668. PubMed ID: 32767072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ultrastructure of Tissue Damage by Amyloid Fibrils.
    Koike H; Katsuno M
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
    Andrei M; Wang JC
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.